These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8310714)

  • 21. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs.
    Huskey SE; Dean BJ; Doss GA; Wang Z; Hop CE; Anari R; Finke PE; Robichaud AJ; Zhang M; Wang B; Strauss JR; Cunningham PK; Feeney WP; Franklin RB; Baillie TA; Chiu SH
    Drug Metab Dispos; 2004 Feb; 32(2):246-58. PubMed ID: 14744948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The disposition of feprazone and its hydroxylated metabolite in human volunteers.
    Berry D; Parke DV
    Xenobiotica; 1988 Jul; 18(7):857-68. PubMed ID: 3176523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic studies of [14C]-flumecinol in humans.
    Klebovich I; Csetényi J; Kerpel-Fronius S; Vereczkey L
    Arzneimittelforschung; 1987 Mar; 37(3):368-71. PubMed ID: 3593454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disposition and metabolism of [14C]-haloperidol in rats.
    Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M
    Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disposition and metabolism of finasteride in dogs.
    Carlin JR; Christofalo P; Arison BH; Ellsworth RE; Rosegay A; Miller RR; Chiu SH; VandenHeuvel WJ
    Drug Metab Dispos; 1997 Jan; 25(1):100-9. PubMed ID: 9010636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of incadronate, a new bisphosphonate, in healthy volunteers and patients with malignancy-associated hypercalcemia.
    Usui T; Oiso Y; Tomita A; Ogata E; Uchida T; Ikeda K; Watanabe T; Higuchi S
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):239-44. PubMed ID: 9208339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.
    Prakash C; Kamel A; Gummerus J; Wilner K
    Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The disposition and metabolism of [14C]fluconazole in humans.
    Brammer KW; Coakley AJ; Jezequel SG; Tarbit MH
    Drug Metab Dispos; 1991; 19(4):764-7. PubMed ID: 1680653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic fate of the thrombolytic agent benzarone in man: comparison with the rat and dog.
    Wood SG; John BA; Chasseaud LF; Bonn R; Grote H; Sandrock K; Darragh A; Lambe RF
    Xenobiotica; 1987 Jul; 17(7):881-96. PubMed ID: 3660858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absorption, disposition, and metabolism of [14C]didanosine in the beagle dog.
    Kaul S; Shyu WC; Shukla UA; Dandekar KA; Barbhaiya RH
    Drug Metab Dispos; 1993; 21(3):447-53. PubMed ID: 8100500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disposition and biotransformation of the antiretroviral drug nevirapine in humans.
    Riska P; Lamson M; MacGregor T; Sabo J; Hattox S; Pav J; Keirns J
    Drug Metab Dispos; 1999 Aug; 27(8):895-901. PubMed ID: 10421616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meropenem clinical pharmacokinetics.
    Mouton JW; van den Anker JN
    Clin Pharmacokinet; 1995 Apr; 28(4):275-86. PubMed ID: 7648757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The metabolic disposition of 14C-ciramadol in humans.
    Sisenwine SF; Liu AL; Tio C; Kimmel H; Freeland G
    Xenobiotica; 1986 Apr; 16(4):335-40. PubMed ID: 3754997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disposition and metabolism of [¹⁴C]PTZ601 in healthy volunteers.
    Flarakos J; Ting LS; Du Y; Stein DS; Reynolds CV; Patel M; Roy S; Mangold JB
    Xenobiotica; 2013 Mar; 43(3):283-92. PubMed ID: 22931187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The fate of [14C]trithiozine in man.
    Renwick AG; Pettet JL; Gruchy B; Corina DL
    Xenobiotica; 1982 May; 12(5):329-43. PubMed ID: 7136001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mass balance, excretion and metabolism of [¹⁴C] ASA404 in cancer patients in a phase I trial.
    McKeage MJ; Fong PC; Hong X; Flarakos J; Mangold J; Du Y; Tanaka C; Schran H
    Cancer Chemother Pharmacol; 2012 May; 69(5):1145-54. PubMed ID: 22212299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disposition in male volunteers of a subanaesthetic intravenous dose of an oil in water emulsion of 14C-propofol.
    Simons PJ; Cockshott ID; Douglas EJ; Gordon EA; Hopkins K; Rowland M
    Xenobiotica; 1988 Apr; 18(4):429-40. PubMed ID: 3261062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disposition and biotransformation of 14C-etodolac in man.
    Ferdinandi ES; Sehgal SN; Demerson CA; Dubuc J; Zilber J; Dvornik D; Cayen MN
    Xenobiotica; 1986 Feb; 16(2):153-66. PubMed ID: 2938343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of meropenem in subjects with various degrees of renal impairment.
    Christensson BA; Nilsson-Ehle I; Hutchison M; Haworth SJ; Oqvist B; Norrby SR
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1532-7. PubMed ID: 1510451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.